Piacquad David
SEC CIK 1602343 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | Dir | 20.1K | — | — | 1 | 2024-06-13 | 2024-06-13 |
Most active insiders at NMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners XII, LLC | 10% | $5.00M | — |
| 2 | ARCH Venture Partners VIII, LLC | 10% | $5.00M | — |
| 3 | Burow Kristina | Dir, 10% | $5.00M | — |
| 4 | Aurora Daljit Singh | See Remarks | — | $1.03M |
| 5 | BERNS PAUL L | See Remarks, Dir | — | $34.5K |
| 6 | Pinto Joshua | Pres | — | $21.1K |
| 7 | Milligan Michael Lee | See Remarks | — | $5,127 |
Piacquad David made no open-market trades at NMRA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-13 | NMRA | Neumora Therapeutics, Inc. | Piacquad David | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations